N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer
download PDF version
Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States.
Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice.
SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
Genome-Wide Linkage Analysis of TMPRSS2-ERG Fusion in Familial Prostate Cancer
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer
Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
Targeted therapy of cancer: new roles for pathologists-prostate cancer
Detection of early prostate cancer using a hepsin-targeted imaging agent
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines
EML4-ALK fusion lung cancer: a rare acquired event 
TMPRSS2-ERG Fusion Heterogeneity in Multifocal Prostate Cancer: Clinical and Biologic Implications
Integrative Microarray Analysis of Pathways Dysregulated in Metastatic Prostate Cancer
TMPRSS2-ETS fusion prostate cancer: biological and clinical implications
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion
A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma
Molecular characterization of the TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: A new perspective for an old model 
Morphological features of TMPRSS2-ERG gene fusion prostate cancer
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
A Hierarchical Naive Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays
Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer
TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
Prognostic factors in lymph node-positive prostate cancer
Defining aggressive prostate cancer using a 12-gene model
How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in sweden 
Internet-based profiler system as integrative framework to support translational research
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Current Thoughts on the Role of the Androgen Receptor and Prostate Cancer Progression
Identification of Two Molecular Groups of Seminomas by Using Expression and Tissue Microarrays
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
Identification of Leukocyte E-Selectin Ligands, P-Selectin Glycoprotein Ligand-1 and E-Selectin Ligand-1, on Human Metastatic Prostate Tumor Cells
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty.
Using molecular markers to predict outcome.
Expression of the Platelet-Derived Growth Factor Receptor in Prostate Cancer and Treatment Implications with Tyrosine Kinase Inhibitors
JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence
Humoral Immune Response to -Methylacyl-CoA Racemase and Prostate Cancer
See editorial: Improved Biomarkers for Prostate Cancer: A Definite Need
Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
The Role of Metastasis - Associated Protein 1 in Prostate Cancer Progression
Effect of finasteride on risk of prostate cancer: How little we really know.
"Gleason grading in France", De La Taille et al.
"Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer"
"alpha-Methylacyl coenzyme A as a Tissue Biomarker for Prostate Cancer"
"Delineation of Prognostic Biomarkers in Prostate Cancer", A.M. Chinnaiyan, M.A. Rubin, et al.
"Understanding Disease Cell by Cell"
United States and Canadian Academy of Pathology
20th Annual Symposium